FDA gives first ever approval to a drug designed to slow Alzheimer's disease

The Food and Drug Administration on Thursday gave its approval to Leqembi, a drug designed to slow the progression of Alzheimer's disease. Leqembi is not considered a cure for Alzheimer’s, but will be covered by Medicare. Dr. Jon LaPook has more. #fda #alzheimers #health "CBS Evening News with Norah O'Donnell" delivers the latest news and original reporting, and goes beyond the headlines with context and depth. Catch the "CBS Evening News" weeknights at 6:30 p.m. ET on the CBS Television Network and at 10 p.m. ET on the CBS News app. Subscribe to the "CBS Evening News" YouTube channel: https://bit.ly/1S7Dhik Watch full episodes of "CBS Evening News": https://cbsn.ws/23XekKA Follow "CBS Evening News" on Instagram: https://bit.ly/1T8icTO Like "CBS Evening News" on Facebook: https://on.fb.me/1KxYobb Follow "CBS Evening News" on Twitter: https://bit.ly/1O3dTTe Download the CBS News app: https://cbsn.ws/1Xb1WC8 Try Paramount+ free: https://bit.ly/2OiW1kZ For video licensing inquiries, contact: licensing@veritone.com